Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • JUNE 2021 Issue has been successfully launched on 1 June 2021.



*Princy Suthar, Neel Sawant, Prof. Mitali Dalwadi and Dr. Umesh Upadhyay


Alzheimer's disease is one of the most death-dealing brain disorders of aged humans. In the past decades, a steady increasing effort for discovering the etiology of the disease and developing pharmacological treatment are noticed. It is the sixth leading cause of death and the most common cause of dementia all over world. It is characterized by progressive cognitive impairment together with declining activities of daily living and behavioural changes. Mild cognitive impairment may increase risk of later developing dementia caused by Alzheimer's disease or other neurological disorders. The clinical symptoms of Alzheimer disease (AD) is dementia that typically begins with indefinite and poor recognizable failure of memory and slowly becomes more severe and, eventually, it prevents from functioning in a normal way. Currently available treatments i.e. acetylcholinesterase inhibitors (rivastigmine, galantamine, donepezil) and N-methyl d-aspartate receptor antagonist (memantine) contribute minimum effect on the disease and target late aspects of the disease. Understanding the stretch of Alzheimer disease related knowledge can assist disease management that result in improved disease management. This article attempts to focus on some of the important recent developments inconception and management of Alzheimer disease.

Keywords: Alzheimer disease (AD), dementia, acetylcholinesterase inhibitors, neurological disorders, N-methyl d-aspartate receptor.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More